Song Paul Y. 4
4 · NKGen Biotech, Inc. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Song Paul Y.
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-12-06+2,000,000→ 2,000,000 totalExercise: $0.44Exp: 2034-12-06→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]On December 6, 2024, the Reporting Person was granted 2,000,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in 48 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2028, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.